Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP470577.RAAkg-x412gtDckHOQ2gqkoRKUnOUwfoUuSTTqWW_5SAU130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470577.RAAkg-x412gtDckHOQ2gqkoRKUnOUwfoUuSTTqWW_5SAU130_provenance.
• NP228192.RAv2V-Es3Em1Z4Xv8dOrpuxI4CNLLIgVyJx0TdF8z209I130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP228192.RAv2V-Es3Em1Z4Xv8dOrpuxI4CNLLIgVyJx0TdF8z209I130_provenance.
• NP396494.RAgNiCj6g216Ph71agxo0f8Bt1I1yNbZnXwVuyFNDFX-c130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396494.RAgNiCj6g216Ph71agxo0f8Bt1I1yNbZnXwVuyFNDFX-c130_provenance.
• NP592599.RA0wdxAGESE0tsyCg2iOVTtNKFzMaQyKDZuKQCG9fg6Cg130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP592599.RA0wdxAGESE0tsyCg2iOVTtNKFzMaQyKDZuKQCG9fg6Cg130_provenance.
• NP936943.RAlirerbVnP3kS52Cox8xBGjSMYYIiGk3DJCfK-KUlp1M130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936943.RAlirerbVnP3kS52Cox8xBGjSMYYIiGk3DJCfK-KUlp1M130_provenance.
• NP513160.RANdrIzraxgSWmVvq4R7OE54M_CsnqXBzotrQj_I69L2Q130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP513160.RANdrIzraxgSWmVvq4R7OE54M_CsnqXBzotrQj_I69L2Q130_provenance.
• assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP612612.RAOkiZzirJSsVqCAoUH3A0ySVPp7wp4PkmV0A1m0IhOEM130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP612612.RAOkiZzirJSsVqCAoUH3A0ySVPp7wp4PkmV0A1m0IhOEM130_provenance.
• assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP246335.RAQvrs-6teAYVs3B2-AncRxEG7cVBJ8wrJtWooY7Fvd_0130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246335.RAQvrs-6teAYVs3B2-AncRxEG7cVBJ8wrJtWooY7Fvd_0130_provenance.
• NP246340.RARzY1K1afCWBfpNSNQltw9QNQY8WRhsY2PFteGCl-huM130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246340.RARzY1K1afCWBfpNSNQltw9QNQY8WRhsY2PFteGCl-huM130_provenance.
• NP641648.RADTnXyU7GAhZyHtira8H4Ju7i_LMpgA4szJXVyDy6tgI130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641648.RADTnXyU7GAhZyHtira8H4Ju7i_LMpgA4szJXVyDy6tgI130_provenance.
• NP246338.RAAdU8aQMJ6uD1Is9ENJuekzT2yfXjblFRDRnFx_eai-U130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246338.RAAdU8aQMJ6uD1Is9ENJuekzT2yfXjblFRDRnFx_eai-U130_provenance.
• NP246342.RAoakyxFXDag_DgcHm0WOZcBOwYKhODqYwKu5dbOqqmMk130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246342.RAoakyxFXDag_DgcHm0WOZcBOwYKhODqYwKu5dbOqqmMk130_provenance.
• NP576318.RA_6IBL6oYV2SToxgd_o7j4YdRGVgfUxJqjYoKCiYlxgg130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576318.RA_6IBL6oYV2SToxgd_o7j4YdRGVgfUxJqjYoKCiYlxgg130_provenance.
• NP641021.RA8q3eelOHT4bB5bbObEg03zGwh7jPdvESB0NFY0riOvQ130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641021.RA8q3eelOHT4bB5bbObEg03zGwh7jPdvESB0NFY0riOvQ130_provenance.
• NP641207.RAzI2Z-eiTfjYh8tIPxq-4TjEKn4LWcZzMxFrPa67u-R4130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641207.RAzI2Z-eiTfjYh8tIPxq-4TjEKn4LWcZzMxFrPa67u-R4130_provenance.
• NP640577.RAzYv11moRq4Y0XD5Yhyw3n38mnK1ulGs8GJCLeWVEPG4130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP640577.RAzYv11moRq4Y0XD5Yhyw3n38mnK1ulGs8GJCLeWVEPG4130_provenance.
• NP246341.RAylNGG6P1xr-HFjWew_SNfcgo3beo5D-HX3gnZIxBAfk130_assertion description "[The present study was designed to prospectively evaluate the role of the TT677 methylenetetrahydrofolate reductase (MTHFR) genotype, the prothrombin G20210A mutation, the factor V G1691A mutation, deficiencies of protein C, protein S, antithrombin, and increased lipoprotein (a) concentrations in leukemic children treated according to the ALL-Berlin-Frankfurt-Muenster (BFM) 90/95 study protocols with respect to the onset of vascular events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246341.RAylNGG6P1xr-HFjWew_SNfcgo3beo5D-HX3gnZIxBAfk130_provenance.